Ka Ting
Sydney, NSW 2050, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.
Journal: Journal of translational medicine
Published: December 22, 2023
Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate.
Journal: Frontiers in immunology
Published: June 23, 2023
The Tumour Vasculature as a Target to Modulate Leucocyte Trafficking.
Journal: Cancers
Published: February 28, 2021
The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours.
Journal: Cancer letters
Published: July 22, 2020
YAP and the RhoC regulator ARHGAP18, are required to mediate flow-dependent endothelial cell alignment.
Journal: Cell communication and signaling : CCS
Published: May 27, 2019
Targeting miR-27a/VE-cadherin interactions rescues cerebral cavernous malformations in mice.
Journal: PLoS biology
Published: May 01, 2019
ARHGAP18: A Flow-Responsive Gene That Regulates Endothelial Cell Alignment and Protects Against Atherosclerosis.
Journal: Journal of the American Heart Association
Published: January 12, 2019
Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: December 14, 2018
Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Journal: Diabetologia
Published: March 09, 2018
Last Updated: 09/26/2026